Medicare Enrolled
Dr. David Shore, M.D.
Endocrinology · Lawrenceville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shore from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shore?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shore
Dr. David Shore is an endocrinology specialist in Lawrenceville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shore performed 2,255 Medicare services across 1,269 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shore received a total of $66,030 from 67 pharmaceutical and/or device companies across 732 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shore is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 26% volume in GA
$66,030 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,255
Medicare services
Top 26% in GA for endocrinology
1,269
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~119 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
927 | $89 | $242 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
497 | $3 | $14 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
283 | $26 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
171 | $57 | $170 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
127 | $72 | $250 |
| Diabetes self-management training, individual Individualized education and training for managing diabetes, billed per 30-minute session. |
75 | $42 | $145 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
53 | $116 | $375 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
42 | $6 | $13 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
23 | $38 | $270 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
20 | $48 | $110 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $125 | $310 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $73 | $210 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$66,030
Total received (2018-2024)
Avg $9,433/year across 7 years
Top 7% in GA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
732
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$45,396 (68.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,215 (24.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,419 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$14,942
2023
$16,761
2022
$17,055
2021
$11,420
2020
$1,500
2019
$2,418
2018
$1,934
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dexcom, Inc.
$6,151
Ascensia Diabetes Care Us Inc.
$3,494
Corcept Therapeutics
$2,595
Abbott Laboratories
$772
Novo Nordisk Inc
$293
Tandem Diabetes Care, Inc.
$235
Amgen Inc.
$213
Lilly USA, LLC
$174
BETA BIONICS, INC.
$151
Galvanize Therapeutics, Inc
$137
SANOFI-AVENTIS U.S. LLC
$130
Xeris Pharmaceuticals, Inc.
$100
Radius Health, Inc.
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$61
Insulet Corporation
$58
Verity Pharmaceuticals Inc.
$51
CeQur Corporation
$38
Nevro Corp.
$33
Bayer Healthcare Pharmaceuticals Inc.
$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$23
Embecta Corp.
$19
Astellas Pharma US Inc
$18
TheracosBio, LLC
$17
Amneal Pharmaceuticals LLC
$17
Amphastar Pharmaceuticals, Inc.
$17
Kyowa Kirin, Inc.
$16
ABBVIE INC.
$15
Top 3 companies account for 81.9% of 2024 payments
All-time payments by company (2018-2024) ›
Dexcom, Inc.
$33,920
DEXCOM, INC.
$9,173
Ascensia Diabetes Care Us Inc.
$3,511
Corcept Therapeutics
$3,217
Novo Nordisk Inc
$2,921
Abbott Laboratories
$2,290
SANOFI-AVENTIS U.S. LLC
$1,391
Amgen Inc.
$1,142
Insulet Corporation
$961
Tandem Diabetes Care, Inc.
$932
AstraZeneca Pharmaceuticals LP
$694
Medtronic, Inc.
$583
IBSA Pharma Inc.
$558
Horizon Therapeutics plc
$516
Lilly USA, LLC
$436
Xeris Pharmaceuticals, Inc.
$301
Janssen Pharmaceuticals, Inc
$220
Bigfoot Biomedical Inc
$212
Amarin Pharma Inc.
$201
Radius Health, Inc.
$196
Boehringer Ingelheim Pharmaceuticals, Inc.
$190
Amneal Pharmaceuticals LLC
$171
BETA BIONICS, INC.
$151
GRT US Holding, Inc.
$142
Medtronic MiniMed, Inc.
$138
Galvanize Therapeutics, Inc
$137
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$136
MannKind Corporation
$111
Becton, Dickinson and Company
$106
AbbVie Inc.
$98
Esperion Therapeutics, Inc.
$92
Regeneron Healthcare Solutions, Inc.
$87
CeQur Corporation
$76
Bayer HealthCare Pharmaceuticals Inc.
$66
Merck Sharp & Dohme Corporation
$63
AbbVie, Inc.
$61
VIVUS, Inc.
$56
Shire North American Group Inc
$54
Verity Pharmaceuticals Inc.
$51
Ultragenyx Pharmaceutical Inc.
$50
Nevro Corp.
$48
VIVUS LLC
$48
Kyowa Kirin, Inc.
$45
Bayer Healthcare Pharmaceuticals Inc.
$44
LIFESCAN, INC.
$35
Currax Pharmaceuticals LLC
$30
Alexion Pharmaceuticals, Inc.
$29
Companion Medical, Inc.
$26
Ipsen Biopharmaceuticals, Inc
$24
Senseonics, Incorporated
$23
PFIZER INC.
$20
Embecta Corp.
$19
Astellas Pharma US Inc
$18
Novartis Pharmaceuticals Corporation
$18
TheracosBio, LLC
$17
Eisai Inc.
$17
Mannkind Corporation
$17
Amphastar Pharmaceuticals, Inc.
$17
ABBVIE INC.
$15
Nalpropion Pharmaceuticals LLC
$15
Averitas Pharma Inc.
$15
Roche Diabetes Care, Inc.
$14
Silk Road Medical, Inc.
$14
Antares Pharma, Inc.
$14
Amryt Pharma Holdings Ltd
$14
Gemini Laboratories, LLC
$13
RECORDATI_RARE_DISEASES_INC.
$13
Top 3 companies account for 70.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ALIYA SYSTEM · Accu-Chek Guide Me · BAQSIMI · BASAGLAR · BD 6cess · BD NANO · BD Nano · Brenzavvy · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · Cryvista · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom CGM · Dexcom G6 Transmitter · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · Lenvima · Licart · MINIMED 780G · MOUNJARO · MYALEPT · Minimed 670G System · Minimed Paradigm Revel · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · ONETOUCH VERIO REFLECT · Omnipod · Ozempic · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · QUTENZA · Qsymia · Qutenza · RAYOS · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Senza · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tymlos · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · Vascepa · Veozah · Victoza · Wegovy · XYOSTED · Xultophy 100/3.6 · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (69%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for endocrinology in GA.
Geographic Context
Endocrinologists within 10 mi
72
Per 100K population
7.4
County median income
$84,823
Nearest hospital
SUMMITRIDGE CENTER- PSYCHIATRY & ADDICTIVE MED
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shore is a clinical cardiology specialist, with above-average Medicare volume (top 26% in GA), with speaking/promotional industry engagement in the top 7% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shore experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shore performed 927 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shore receive payments from pharmaceutical companies?
Yes. Dr. Shore received a total of $66,030 from 67 companies across 732 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shore's costs compare to other endocrinologists in Lawrenceville?
Dr. Shore's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shore) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Lawrenceville
Browse endocrinologists in Lawrenceville ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in GA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in GA
Which GA endocrinologists receive the most from drug and device companies.
By company
Dexcom, Inc. Payments to Doctors
See all physicians who received payments from Dexcom, Inc.
By company
DEXCOM, INC. Payments to Doctors
See all physicians who received payments from DEXCOM, INC.
By company
Ascensia Diabetes Care Us Inc. Payments to Doctors
See all physicians who received payments from Ascensia Diabetes Care Us Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology